Orthobiologics in Hand Surgery. [Review] 

 -  2021 
<br/><br/>Available in print through MWHC library: 1999 - 2002, Available online from MWHC library: 1995 - present 
<br/><br/> Orthobiologic agents are used as innovative adjuvant therapy to treat common upper-extremity pathology, including carpal tunnel syndrome, de Quervain tenosynovitis, and distal radius fractures. In this article, we perform a narrative review and evaluate current literature on orthobiologics in the upper extremity. Orthobiologics evaluated include bone morphogenetic proteins, platelet-rich plasma, bone marrow aspirate concentrate, mesenchymal stem cells, and amniotic membrane. Studies selected include randomized control trials, case studies, and animal studies. Although there is some clinical evidence regarding the use of orthobiologic agents in the treatment of shoulder, elbow, and sports injuries, there is a paucity of literature regarding their use to treat pathology of the hand and wrist. Further investigation is necessary to determine their effectiveness and therapeutic value in treatment of upper extremity injuries. Copyright (c) 2021 American Society for Surgery of the Hand. Published by Elsevier Inc. All rights reserved. 
<br/><br/><br/>English 
<br/><br/><label>ISSN: </label>0363-5023 
<br/><br/><label>Standard No.: </label>10.1016/j.jhsa.2021.01.006 [doi] S0363-5023(21)00033-2 [pii] 
<br/><br/><label>Subjects--Topical Terms: </label><br/>IN PROCESS -- NOT YET INDEXED
<br/><br/><label>Subjects--Geographic Terms: </label><br/>Curtis National Hand Center
<br/><br/><label>Index Terms--Function: </label><br/>Journal Article<br/>Review